SHERWIN STEPHEN A

CIK 000107946211 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001079462

Recent Transactions

50 trades

Gift
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-09-02−1,000→ 12,542 total
Award
BIOGEN INC.$BIIB
Common Stock
2025-06-17+2,370→ 13,688 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-05-22−2,869→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-05-22+2,869→ 13,542 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-05-21+3,318→ 3,318 total
Sale
BIOGEN INC.$BIIB
Common Stock
2025-03-07$150.02/sh−8,760→ 11,318 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.69/sh−13,831→ 10,673 total
Gift
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-11-04−2,000→ 24,504 total
Award
BIOGEN INC.$BIIB
Common Stock
2024-06-21+1,340→ 20,078 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-29$133.46/sh−25,000→ 26,504 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-05-29−25,000→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-29$42.76/sh+25,000→ 51,504 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-29$47.89/sh+15,000→ 41,504 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-05-29−15,000→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-29$133.47/sh−15,000→ 26,504 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-05-22+2,869→ 2,869 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-05-17−4,199→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-17+4,199→ 26,504 total
Gift
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-11-16−2,750→ 22,305 total
Award
BIOGEN INC.$BIIB
Common Stock
2023-06-26+960→ 18,738 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2023-05-17+4,199→ 4,199 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-01-03$12.71/sh−15,000→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-01-03$12.98/sh−15,000→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-01-03$12.98/sh+15,000→ 40,055 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-01-03$118.85/sh−15,000→ 25,055 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-01-03$12.71/sh+15,000→ 40,055 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-01-03$118.87/sh−15,000→ 25,055 total
Gift
BIOGEN INC.$BIIB
Common Stock
2022-11-15−695→ 17,778 total
Award
BIOGEN INC.$BIIB
Common Stock
2022-06-15+1,370→ 18,473 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2022-05-18+9,724→ 9,724 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2022-01-24$6.66/sh−15,000→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2022-01-24$6.66/sh+15,000→ 40,055 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2022-01-24$74.43/sh−15,000→ 25,055 total
Gift
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2021-12-14−2,000→ 25,055 total
Award
BIOGEN INC.$BIIB
Common Stock
2021-07-01+775→ 17,103 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2021-05-19+8,833→ 8,833 total
Gift
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2020-12-03−2,806→ 27,055 total
Award
BIOGEN INC.$BIIB
Common Stock
2020-06-03+890→ 16,328 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2020-05-19+6,018→ 6,018 total
Disposition to Issuer
Neon Therapeutics, Inc.
Common Stock
2020-05-06−45,000→ 0 total
Disposition to Issuer
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-06−18,500→ 0 total
Disposition to Issuer
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-06−14,000→ 0 total
Disposition to Issuer
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-06−5,000→ 0 total
Award
CHINOOK THERAPEUTICS, INC.
Stock Option (Right to Buy)
2020-05-05+30,000→ 30,000 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2020-04-28$99.39/sh−17,687→ 29,861 total
Exercise/Conversion
BIOGEN INC.$BIIB
Stock Option (Right to Buy)
2020-03-11−1,355→ 0 total
Sale
BIOGEN INC.$BIIB
Common Stock
2020-03-11$295.29/sh−270→ 15,438 total
Exercise/Conversion
BIOGEN INC.$BIIB
Common Stock
2020-03-11$58.46/sh+10,923→ 16,517 total
Exercise/Conversion
BIOGEN INC.$BIIB
Common Stock
2020-03-11$58.46/sh+1,355→ 15,708 total
Exercise/Conversion
BIOGEN INC.$BIIB
Stock Option (Right to Buy)
2020-03-11−10,923→ 0 total

Companies

Recent Filings

Address

CELL GENESYS, INC., 400 OYSTER PT. BLVD., STE. 525

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov